12,219 followers
RT @FrontOncology: New research: Regorafenib combined with sintilimab as second-line treatment for advanced HCC patient: a case report: Hep…
RT @FrontOncology: New research: Regorafenib combined with sintilimab as second-line treatment for advanced HCC patient: a case report: Hep…
RT @FrontOncology: New research: Regorafenib combined with sintilimab as second-line treatment for advanced HCC patient: a case report: Hep…
New research: Regorafenib combined with sintilimab as second-line treatment for advanced HCC patient: a case report: Hepatocellular carcinoma (HCC) is a tumor with a high degree of malignancy. Patients have poor outcomes and short survival… https://t.co/GZ